Biologists have built a better antibody in an effort to neutralize the many subtypes of HIV. The work builds on earlier efforts that involved using highly potent antibodies isolated from HIV-positive people. Now, a team from the California Institute of Technology (Caltech) has used one of these naturally occurring antibodies to create a stronger version—one the researchers believe is a better candidate for clinical applications.
